Implementation of a cefazolin-based stewardship pathway for methicillin-susceptible Staphylococcus aureus bloodstream infections paired with infectious diseases consultation.

@article{Lee2017ImplementationOA,
  title={Implementation of a cefazolin-based stewardship pathway for methicillin-susceptible Staphylococcus aureus bloodstream infections paired with infectious diseases consultation.},
  author={Benjamin John Lee and Sonia N Rao and Sheila K. Wang and Jane Y Lee and Irfana Y Lakada and Elise M. Gilbert and Viktorija O. Barr and Michael J Postelnick and Sarah H. Sutton and Teresa R. Zembower and Maureen K. Bolon and Marc H Scheetz and Nathaniel J. Rhodes},
  journal={International journal of antimicrobial agents},
  year={2017},
  volume={49 5},
  pages={
          650-654
        }
}
Methicillin-susceptible Staphylococcus aureus (MSSA) infections have been successfully treated both with cefazolin and antistaphylococcal penicillins; cefazolin appears effective in MSSA bloodstream infections (BSIs). Thus, our antimicrobial stewardship programme (ASP) implemented a clinical pathway supporting cefazolin use in MSSA-BSIs and restricting oxacillin use to infectious diseases (ID) consultation due to cefazolin's lower cost and more convenient dosing. This before and after quasi… CONTINUE READING